Hatchtech completes $12.5M capital raise, secures funds for phase III trial and NDA submissions, and announces board changes

chevron_leftPreviosly
Lice feel the itch over Hatchtech deal
01 November 2013

You may also like

16 September 2018

VC-backed women’s health company Madorra to begin clinical trials in Australia

17 April 2012

Best Venture Capital Investment at the 2012 Vaccine Industry Excellence Awards

Awards, Media Release

19 May 2020

OneVentures expands team to internationalise its healthcare portfolio

31 October 2013

Hatchtech completes $12.5M capital raise, secures funds for phase III trial and NDA submissions, and announces board changes

26 October 2010

Hatchtech raises $6.3m for DeOvo™ Head Lice Phase 2b Clinical Trial

26 August 2014

Vaxxas Selected as World Economic Forum Technology Pioneer 2015

Awards, Media Release

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor